Diagnostic detection of diffuse glioma tumors in vivo with molecular fluorescent probe-based transmission spectroscopy

Summer Gibbs, Julia A. O'Hara, Subhadra Srinivasan, P. Jack Hoopes, Tayyaba Hasan, Brian W. Pogue

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The diffuse spread of glioma tumors leads to the inability to image and properly treat this disease. The optical spectral signature of targeted fluorescent probes provides molecular signals from the diffuse morphologies of glioma tumors, which can be a more effective diagnostic probe than standard morphology-based magnetic resonance imaging (MRI) sequences. Three orthotopic xenograft glioma models were used to examine the potential for transmitted optical fluorescence signal detection in vivo, using endogenously produced protoporphyrin IX (PpIX) and exogenously administered fluorescently labeled epidermal growth factor (EGF). Accurate quantification of the fluorescent signals required spectral filtering and signal normalization, and when optimized, it was possible to improve detection of sparse diffuse glioma tumor morphologies. The signal of endogenously produced PpIX provided similar sensitivity and specificity to MRI, while detection with fluorescently labeled EGF provided maximal specificity for tumors with high EGF receptor activity. Optical transmitted fluorescent signal may add significant benefit for clinical cases of diffuse infiltrative growth pattern glioma tumors given sufficient optimization of the signal acquisition for each patient.

Original languageEnglish (US)
Pages (from-to)974-983
Number of pages10
JournalMedical Physics
Volume36
Issue number3
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Molecular Probes
Fluorescent Dyes
Glioma
Spectrum Analysis
Neoplasms
Epidermal Growth Factor
Magnetic Resonance Imaging
Epidermal Growth Factor Receptor
Heterografts
Fluorescence
Sensitivity and Specificity
Growth

Keywords

  • Fluorescence
  • Glioma
  • Imaging
  • Magnetic resonance
  • Protein

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Diagnostic detection of diffuse glioma tumors in vivo with molecular fluorescent probe-based transmission spectroscopy. / Gibbs, Summer; O'Hara, Julia A.; Srinivasan, Subhadra; Hoopes, P. Jack; Hasan, Tayyaba; Pogue, Brian W.

In: Medical Physics, Vol. 36, No. 3, 2009, p. 974-983.

Research output: Contribution to journalArticle

Gibbs, Summer ; O'Hara, Julia A. ; Srinivasan, Subhadra ; Hoopes, P. Jack ; Hasan, Tayyaba ; Pogue, Brian W. / Diagnostic detection of diffuse glioma tumors in vivo with molecular fluorescent probe-based transmission spectroscopy. In: Medical Physics. 2009 ; Vol. 36, No. 3. pp. 974-983.
@article{aff25ddbe5ea4531b8b1cc6d0e4583a3,
title = "Diagnostic detection of diffuse glioma tumors in vivo with molecular fluorescent probe-based transmission spectroscopy",
abstract = "The diffuse spread of glioma tumors leads to the inability to image and properly treat this disease. The optical spectral signature of targeted fluorescent probes provides molecular signals from the diffuse morphologies of glioma tumors, which can be a more effective diagnostic probe than standard morphology-based magnetic resonance imaging (MRI) sequences. Three orthotopic xenograft glioma models were used to examine the potential for transmitted optical fluorescence signal detection in vivo, using endogenously produced protoporphyrin IX (PpIX) and exogenously administered fluorescently labeled epidermal growth factor (EGF). Accurate quantification of the fluorescent signals required spectral filtering and signal normalization, and when optimized, it was possible to improve detection of sparse diffuse glioma tumor morphologies. The signal of endogenously produced PpIX provided similar sensitivity and specificity to MRI, while detection with fluorescently labeled EGF provided maximal specificity for tumors with high EGF receptor activity. Optical transmitted fluorescent signal may add significant benefit for clinical cases of diffuse infiltrative growth pattern glioma tumors given sufficient optimization of the signal acquisition for each patient.",
keywords = "Fluorescence, Glioma, Imaging, Magnetic resonance, Protein",
author = "Summer Gibbs and O'Hara, {Julia A.} and Subhadra Srinivasan and Hoopes, {P. Jack} and Tayyaba Hasan and Pogue, {Brian W.}",
year = "2009",
doi = "10.1118/1.3075770",
language = "English (US)",
volume = "36",
pages = "974--983",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "3",

}

TY - JOUR

T1 - Diagnostic detection of diffuse glioma tumors in vivo with molecular fluorescent probe-based transmission spectroscopy

AU - Gibbs, Summer

AU - O'Hara, Julia A.

AU - Srinivasan, Subhadra

AU - Hoopes, P. Jack

AU - Hasan, Tayyaba

AU - Pogue, Brian W.

PY - 2009

Y1 - 2009

N2 - The diffuse spread of glioma tumors leads to the inability to image and properly treat this disease. The optical spectral signature of targeted fluorescent probes provides molecular signals from the diffuse morphologies of glioma tumors, which can be a more effective diagnostic probe than standard morphology-based magnetic resonance imaging (MRI) sequences. Three orthotopic xenograft glioma models were used to examine the potential for transmitted optical fluorescence signal detection in vivo, using endogenously produced protoporphyrin IX (PpIX) and exogenously administered fluorescently labeled epidermal growth factor (EGF). Accurate quantification of the fluorescent signals required spectral filtering and signal normalization, and when optimized, it was possible to improve detection of sparse diffuse glioma tumor morphologies. The signal of endogenously produced PpIX provided similar sensitivity and specificity to MRI, while detection with fluorescently labeled EGF provided maximal specificity for tumors with high EGF receptor activity. Optical transmitted fluorescent signal may add significant benefit for clinical cases of diffuse infiltrative growth pattern glioma tumors given sufficient optimization of the signal acquisition for each patient.

AB - The diffuse spread of glioma tumors leads to the inability to image and properly treat this disease. The optical spectral signature of targeted fluorescent probes provides molecular signals from the diffuse morphologies of glioma tumors, which can be a more effective diagnostic probe than standard morphology-based magnetic resonance imaging (MRI) sequences. Three orthotopic xenograft glioma models were used to examine the potential for transmitted optical fluorescence signal detection in vivo, using endogenously produced protoporphyrin IX (PpIX) and exogenously administered fluorescently labeled epidermal growth factor (EGF). Accurate quantification of the fluorescent signals required spectral filtering and signal normalization, and when optimized, it was possible to improve detection of sparse diffuse glioma tumor morphologies. The signal of endogenously produced PpIX provided similar sensitivity and specificity to MRI, while detection with fluorescently labeled EGF provided maximal specificity for tumors with high EGF receptor activity. Optical transmitted fluorescent signal may add significant benefit for clinical cases of diffuse infiltrative growth pattern glioma tumors given sufficient optimization of the signal acquisition for each patient.

KW - Fluorescence

KW - Glioma

KW - Imaging

KW - Magnetic resonance

KW - Protein

UR - http://www.scopus.com/inward/record.url?scp=61349155416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349155416&partnerID=8YFLogxK

U2 - 10.1118/1.3075770

DO - 10.1118/1.3075770

M3 - Article

C2 - 19378758

AN - SCOPUS:61349155416

VL - 36

SP - 974

EP - 983

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 3

ER -